Jeito Capital announces the acquisition by Merck & Co (NYSE: MRK) of its portfolio company EyeBio for a potential value of $3 billion
May 29, 2024 07:02 ET
|
Jeito Capital
Jeito Capital announces the acquisition by Merck & Co (NYSE: MRK)of its portfolio company EyeBio for a potential value of $3 billion This acquisition reflects the significant clinical progress...
Gildan Activewear Reports on Shareholders’ Voting Results
May 29, 2024 07:00 ET
|
Gildan Activewear, Inc.
MONTRÉAL, May 29, 2024 (GLOBE NEWSWIRE) -- Gildan Activewear Inc. (GIL: TSX and NYSE) (“Gildan” or the “Company”) today announced that the eight director nominees, being all of the existing...
Omega Therapeutics Appoints Kaan Certel, Ph.D., as Chief Business Officer
May 29, 2024 07:00 ET
|
Omega Therapeutics
CAMBRIDGE, Mass., May 29, 2024 (GLOBE NEWSWIRE) -- Omega Therapeutics, Inc. (Nasdaq: OMGA) (“Omega”), a clinical-stage biotechnology company pioneering the development of a new class of programmable...
Invivyd to Present Data at 2024 American Society of Clinical Oncology (ASCO) Annual Meeting and 2024 American Transplant Congress (ATC)
May 29, 2024 07:00 ET
|
Invivyd
WALTHAM, Mass., May 29, 2024 (GLOBE NEWSWIRE) -- Invivyd, Inc. (Nasdaq: IVVD), a biopharmaceutical company devoted to delivering protection from serious viral infectious diseases, today announced...
ACELYRIN, INC. Announces Lonigutamab Phase 1/2 Proof-Of-Concept Data to be Shared During Late-Breaking Oral Presentation at ENDO 2024
May 29, 2024 07:00 ET
|
ACELYRIN, INC.
Lonigutamab is the first subcutaneous anti-IGF-1R to demonstrate clinical responses in thyroid eye disease (TED) patients LOS ANGELES, May 29, 2024 (GLOBE NEWSWIRE) -- ACELYRIN, INC. (Nasdaq:...
Augmedix Appoints Alex Stinard, M.D., as Chief Clinical AI Officer
May 29, 2024 07:00 ET
|
Augmedix Inc
SAN FRANCISCO, May 29, 2024 (GLOBE NEWSWIRE) -- Augmedix (Nasdaq: AUGX), a leader in ambient artificial intelligence (AI) medical documentation and data solutions, today announced that Alex Stinard,...
Bitfarms Responds to Unsolicited Proposal from Riot Platforms
May 29, 2024 07:00 ET
|
Bitfarms Ltd.
Company Committed to Maximizing Value for All Shareholders; Strategic Alternatives Process Underway Reaffirms Confidence in Business and Guidance of 21 EH/s and 21 w/TH in 2024 This news...
Dragonfly Energy to Participate in June 2024 Conferences
May 29, 2024 07:00 ET
|
Dragonfly Energy Holdings Corp.
RENO, Nev., May 29, 2024 (GLOBE NEWSWIRE) -- Dragonfly Energy Holdings Corp. (“Dragonfly Energy” or the “Company”) (Nasdaq: DFLI), maker of Battle Born Batteries® and an industry leader in energy...
Milestone Pharmaceuticals Announces FDA Acceptance of New Drug Application for CARDAMYST™
May 29, 2024 07:00 ET
|
Milestone Pharmaceuticals Inc.
MONTREAL and CHARLOTTE, N.C., May 29, 2024 (GLOBE NEWSWIRE) -- Milestone® Pharmaceuticals Inc. (Nasdaq: MIST), a biopharmaceutical company focused on the development and commercialization of...
Axsome Therapeutics Highlights Data on Solriamfetol Demonstrating Improvement in Cognitive Function in Patients with Obstructive Sleep Apnea or Narcolepsy at SLEEP 2024
May 29, 2024 07:00 ET
|
Axsome Therapeutics, Inc.
NEW YORK, May 29, 2024 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company developing and delivering novel therapies for the management of central nervous...
- May 29, 2024 06:54 ET Europe and ASEAN Frozen Food Market Forecast at $194.62 Billion by 2030 - Consumer Patterns Analyzed by Income, Age, Gender, and Lifestyle Choices
- May 29, 2024 06:51 ET $750+ Mn Acoustic Emission (AE) Testing Market - Global and Regional Analysis Report 2024-2034 Featuring Prominent Players - TUV Rheinland, PARKER HANNIFIN, Vallen Systeme, GE, MISTRAS, & KRN Services